Advertisement
Lululemon Athletica Boosts Q4 Revenue Outlook - Quick Facts
(RTTNews) - Ahead of the meeting with analysts and investors at the ICR Conference, athletic apparel company lululemon athletica inc. (LULU) on Monday narrowed its earnings guidance range for the fourth quarter, while raising net revenue outlook for the quarter.
For the fourth quarter, the company now expects earnings in a range of $4.22 to $4.27 per share on net revenue between $2.660 billion and $2.700 billion.
Previously, the company expected earnings in the range of $4.20 to $4.30 per share on net revenue between $2.605 billion and $2.655 billion.
On average, analysts polled by Thomson Reuters currently expect the company to report earnings of $4.30 per share on revenues of $2.67 billion for the quarter.
read more
Lululemon Athletica Boosts Q4 Outlook
Ahead of the meeting with analysts and investors at the ICR Conference later on Monday, athletic apparel company lululemon athletica inc. (LULU) raised its earnings and revenue guidance for the fourth quarter.
RTTNews
|
511天前
Swiss GDP Growth Accelerates In Q1
Switzerland's economic growth accelerated in the first quarter on a notable rebound in exports to the US ahead of the increase in trade tariffs, official data revealed on Monday. Gross domestic product expanded by adjusted 0.8 percent sequentially after rising 0.6 percent in the fourth quarter of 2024, the State Secretariat for Economic Affairs, or SECO, reported.
RTTNews
|
14分鐘前
CAC 40 Remains Weak Despite Coming Off Early Lows
French stocks are exhibiting weakness on Monday, extending recent losses, amid renewed concerns about trade tensions following U.S. President Donald Trump's announcement that tariffs on steel and aluminium will be increased to 50% from June 4th. Escalating tensions between the U.S. and China also contribute to the weakening sentiment.
RTTNews
|
22分鐘前
U.S. Dollar Falls Against Majors
The U.S. dollar weakened against other major currencies in the European session on Monday.
RTTNews
|
26分鐘前
Moderna Shares Gain On FDA Approval For New COVID-19 Vaccine
Shares of Moderna, Inc. were gaining around 5 percent in the pre-market activity on the Nasdaq after its new Covid-19 vaccine, mNEXSPIKE, received approval from the U.S. Food and Drug Administration for limited use. mNEXSPIKE (mRNA-1283), a new vaccine to protect against COVID-19, is for people who have received a COVID-19 vaccine before. It can now be used in all adults 65 and older, as well as..
RTTNews
|
29分鐘前
DAX Down Nearly 0.5% In Cautious Trade Amid Trade Tensions
German stocks are down in negative territory on Monday, weighed down by concerns about trade tensions following China and the U.S. accusing each other of violating their trade agreements.
RTTNews
|
59分鐘前
European Shares Mostly Lower Amid Global Trade Tensions
European stocks were broadly lower on Monday as U.S. President Donald Trump's decision to double tariffs on steel and aluminum imports along with rising Sino-U.S. tensions threatened to rekindle global trade tensions.
RTTNews
|
1小時21分鐘前
Asian Shares Retreat On US-China Tensions
Asian stocks closed mostly lower in thin trade on Monday, with mainland China, New Zealand and Malaysian markets closed for holidays.
RTTNews
|
1小時47分鐘前
